Pricing Log in Create free account

Quince Therapeutics, Inc. (IRLA) vs 4D pharma PLC Sponsored ADR (LBPS)

Quince Therapeutics, Inc. and 4D pharma PLC Sponsored ADR are both Biotechnology companies. 4D pharma PLC Sponsored ADR is the larger, with a market value of $37.2M against $33.8M — 1.1× the size. Quince Therapeutics, Inc. has the higher net margin (0.00% vs −2,010.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Quince Therapeutics, Inc. leads on 8 and 4D pharma PLC Sponsored ADR on 2.

Valuation

Metric IRLA LBPS Biotechnology median
P/E n/m n/m 8.50
P/S n/m 211.23 9.71
P/B n/m 9.49 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m — 0.64
EV/Sales n/m — 9.21
Earnings yield (442.37%) (40.76%) (33.15%)
Free cash flow yield (23.96%) (30.32%) (25.50%)

Profitability

Metric IRLA LBPS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (2,010.89%) 0.00%
Free cash flow margin 0.00% (3,283.80%) 0.00%
Return on equity 784.09% (155.83%) (56.36%)
Return on assets (76.68%) (77.95%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IRLA LBPS Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (28.24%) 35.04% 30.26%
Revenue growth, 5-year CAGR — 21.70% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IRLA LBPS Biotechnology median
Debt to equity 0.00 0.43 0.00
Current ratio 14.52 5.21 4.72
Net debt to EBITDA 0.00 0.23 0.96

Dividend

Metric IRLA LBPS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IRLA LBPS Biotechnology median
Market cap 33.79m 37.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack